|
AHDB is now included in the Cumulative Index to Nursing
and Allied Health Literature (CINAHL)
Editorial
Contracting for Compliance: Using Adherence as a
Patient-Centered Measure of Performance
By Scott R. Taylor, RPh, MBA; J.B. Jones, MBA;
Nirav R. Shah, MD, MPH
With US health spending expected to reach $3.6 trillion by 2014,
all stakeholders are seeking….… FULL ARTICLE
Business
Wayward Prescriptions: Costs of Fraud in Payor Plans
By Thomas Kaye, RPh, MBA
The recent events surrounding the incidences of heparin
contamination from China that was possibly willful…
FULL ARTICLE
Stakeholder Perspectives by Susan Sarnoff, DSW
Clinical
Prescribing Warfarin Appropriately to Meet Patient
Safety Goals
By Lekshmi Dharmarajan, MD, FACP, FACC;
T.S. Dharmarajan, MD, FACP, AGSF
Warfarin, which has been in use for more than 50 years,
has received considerable attention because of its common use…
FULL ARTICLE
Stakeholder Perspective by Teresa DeLuca, MD, MBA
Regulatory
Treading Water: The No-Growth Investment
in Health Services Research
By Emily J. Holubowich, MPP; Joseph R. Antos, PhD
Health services research explores healthcare costs, quality,
and access and seeks ways to improve healthcare delivery, safety…
FULL ARTICLE
Stakeholder Perspective by Joseph R. Antos, PhD
Generic Drug Trends
FDA Bolsters Its Generic Approval Process: Health Plans
Reap the Benefits
FULL ARTICLE
Stakeholder Perspective by Gary M. Owens, MD
FDA Watch
Heparin at the Center of the Storm
By Mark Senak, JD
FULL ARTICLE
ADA MEETING HIGHLIGHTS
Bustling Pipeline for Diabetes and Its
Metabolic Consequences
By Wayne Kuznar
FULL ARTICLE
ISPOR Primer
The International Society for Pharmacoeconomics
and Outcomes Research: Implications for Decision
Makers in Healthcare
By Gordon M. Cummins, MS
FULL ARTICLE
ISPOR MEETING HIGHLIGHTS
By Rosemary Frei, MSc
Testing for Diabetes Reduces Healthcare Costs…
Cost-Analysis of Bortezomib Use at Major Cancer Center…
Repeat Testing Needed to Estimate US Health Expenditures…
FULL ARTICLE
|